Mylan to supply investigational antiviral remdesivir for COVID-19 treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
We just got another reason to be optimistic about a potential coronavirus treatment from Gilead (GILD)
Associated Press A Chicago hospital treating severe COVID-19 patients with Gilead Sciences' antiviral medication remdesivir is seeing recoveries in patients' symptoms, Stat News reports. Stat .....»»
Gilead Analyst Sees Catalyst Ahead In Data Readout For Potential Coronavirus Treatment
Gilead Sciences, Inc.'s (NASDAQ: GILD) remdesivir is one of the frontrunners among investigational drugs to treat COVID-19. Latest.....»»
Gilead To Donate 1.5M Doses Of Experimental Coronavirus Treatment: "The Right Thing To Do"
Gilead Sciences, Inc. (NASDAQ: GILD) is donating 1.5 million doses of remdesivir, its investigational drug for COVID-19, for compassionate use, expanded access and clinical trials, Chairman and CEO Daniel O'Day said Saturday. read more.....»»
Analyst Says Gilead"s Remdesivir Could Be Approved "Within Months" For COVID-19 Treatment
A senior research analyst at Piper Sandler believes Gilead Sciences Inc.'s (NASDAQ: GILD) Remdesivir antiviral may soon be approved for COVID-19 treatm.....»»
Eli Lilly to boost supply of Covid treatment in India, Reuters reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
A Word from the Experts: It’s a ‘question of time’ before another virus jumps from animal to human, says co-inventor of flu treatment Tamiflu. Preventative therapies are needed.
Nobert Bischofberger helped discover Tamiflu, a well-known antiviral flu treatment. Here's why he thinks the U.S. hasn't put enough emphasis on preventative COVID-19 therapies......»»
: AstraZeneca to supply U.S. with extra 500,000 doses of COVID-19 antibody-based cocktail
AZD7442 is being evaluated for the prevention and treatment of COVID-19 in late-stage trials in more than 9,000 participants around the world......»»
Merck to receive up to $356 mln from U.S. gov"t for a supply of a potential COVID-19 treatment
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Arbutus Reports First Quarter 2020 Financial Results, Provides Pipeline Update and Announces New Research Initiative to Identify Novel Antiviral Therapies for the Treatment of Coronavirus Infections
Arbutus remains on track to achieve its key 2020 objectives despite COVID-19 chall.....»»
Administration pushed use of remdesivir, but unequal rollout angers doctors
Doctors and hospitals say the Trump administration’s plan to distribute the covid-19 treatment does not seem fair and lacks transparency......»»
Gilead Sciences Gains Remdesivir Approval in Japan
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment......»»
How does Gilead market a pandemic treatment?
In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»
How does Gilead market a pandemic treatment?
In a matter of weeks, remdesivir has gone from a shelved, failed hepatitis C treatment to the center of a national effort to treat patients suffering from covid-19, the illness caused by the novel coronavirus......»»
Trump administration pushed use of remdesivir, but unequal rollout angers doctors
Doctors and hospitals say the Trump administration’s plan to distribute the covid-19 treatment does not seem fair and lacks transparency......»»
Infectious-disease doctors ask government to explain how it decides who gets Gilead’s remdesivir
Within a week of the Food and Drug Administration authorization of remdesivir as a COVID-19 treatment, clinicians are pushing the Trump administration to clarify how it is selecting which hospitals get access to the drug......»»
Gilead Works To "Maximize Global Supply" Of Coronavirus Candidate Remdesivir Amid Threat Of Patent Loss
Gilead Sciences, Inc. (NASDAQ: GILD) recently received emergency use authorization from the FDA for its coronavirus treatment candidate remdesivir. read more.....»»
Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says
The CEO of Gilead Sciences says U.S. hospitals should get enough of its drug to fight COVID-19 to treat as many as 200,0.....»»
Gilead confirms Remdesivir received FDA EUA in COVID-19 treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA grants Gilead’s remdesivir emergency authorization for COVID-19 treatment
The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment......»»
FDA clears Gilead"s emergency coronavirus treatment remdesivir
The Food and Drug Administration has authorized the emergency use of Gilead’s experimental drug remdesivir for COVID-19 treatment......»»